Table I.
Bilirubin, n (%) | |||
---|---|---|---|
|
|||
Features | ≥20% decrease | Increase or minor change | P-value |
Age, years | |||
>70 | 19 (67.9) | 9 (32.1) | 0.295 |
≤70 | 59 (79.7) | 15 (20.3) | |
Gender | |||
Male | 46 (69.7) | 20 (30.3) | 0.052 |
Female | 32 (88.9) | 4 (11.1) | |
Obstruction level | |||
Hilar | 13 (72.2) | 5 (27.8) | 0.760 |
Non-hilar | 65 (77.4) | 19 (22.6) | |
Liver metastases | |||
Present | 24 (70.6) | 10 (29.4) | 0.033 |
Absent | 54 (79.4) | 14 (20.6) | |
Bilirubin prior to PTBD, μmol/l | |||
>342 | 26 (81.2) | 6 (18.8) | 0.616 |
≤342 | 52 (76.5) | 18 (23.5) |
PTBD, percutaneous transhepatic biliary drainage.